作为选择性抗癌剂的triterpenoid phthalimides,其向线粒体亡
Anna Kazakova1, Ivo Frydrych2, Nikola Jakubcová3
1Department of Organic Chemistry, Faculty of Science, Palacký University Olomouc, 17. listopadu 1192/12, 779 00, Olomouc, Czech Republic.
European journal of medicinal chemistry
|December 14, 2024
概括
新的三类衍生物显示出强大的抗癌活性. 这些化合物通过诱导亡和破坏DNA复制来有效地杀死癌细胞,标记它们为有前途的候选药物.
科学领域:
- 药用化学 医学化学
- 有机合成 有机合成
- 癌症生物学 癌症生物学
背景情况:
- 三聚类是具有多种生物活动的天然产品.
- 开发新的细胞毒剂对于癌症治疗至关重要.
研究的目的:
- 为了合成新型的三类衍生物.
- 评估这些化合物对各种癌症细胞系的体外细胞毒性和抗增殖活性.
主要方法:
- 替代代因的合成和随后的迪尔斯-阿尔德反应.
- 制备55种新型的三类酸盐,酸胺和相关衍生物.
- 在实验室中对八种癌症和两种非癌细胞系进行细胞毒性测定.
- 亡诱导研究,线粒体脱极化测定和西方斑点分析.
- 对DNA复制和转录活动的评估.
- 对PI3K/Akt和STAT3信号通路的分析.
主要成果:
- 合成了55种新的三类衍生物.
- 四种化合物 (19,26,28,30) 对CCRF-CEM细胞表现出显著的细胞毒性 (IC50 ≤5μM).
- 这些活性化合物诱导了亡,线粒体脱极化,并破坏了DNA复制和转录.
- 观察到PI3K/Akt和STAT3通路的调节.
结论:
- 合成的三烯酸衍生物具有显著的抗增殖和细胞毒性.
- 化合物19,26,28和30通过诱导亡和途径调节表现出强大的抗癌活性.
- 这些已识别的化合物代表了癌症治疗中进一步临床前发展的有希望的候选者.
相关概念视频
Electron Transport Chain: Complex I and II
11.3K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
11.3K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Drugs that Destabilize Microtubules
1.9K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
1.9K
The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K


